(Q26829932)

language of work or name

1 reference

August 2014

1 reference

Journal of Neurochemistry

published in

1 reference

volume

130

1 reference

issue

3

1 reference

page(s)

328-50

1 reference

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

cites work

1 reference

Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors

21 January 2018

1 reference

Chemistry and biology of eukaryotic iron metabolism

21 January 2018

1 reference

Genetics and molecular biology of Huntington's disease

21 January 2018

1 reference

Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease

21 January 2018

1 reference

Ferritins: a family of molecules for iron storage, antioxidation and more.

21 January 2018

1 reference

Protein aggregates in Huntington's disease.

21 January 2018

1 reference

Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity

21 January 2018

1 reference

The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin.

21 January 2018

1 reference

Intergenerational CAG repeat instability is highly heritable in Huntington's disease

21 January 2018

1 reference

Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease

21 January 2018

1 reference

Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients.

21 January 2018

1 reference

Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores

21 January 2018

1 reference

Increased basal ganglia iron levels in Huntington disease

21 January 2018

1 reference

Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases

21 January 2018

1 reference

Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications

21 January 2018

1 reference

Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin

21 January 2018

1 reference

Global changes to the ubiquitin system in Huntington's disease.

21 January 2018

1 reference

Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity

21 January 2018

1 reference

Calcium signaling and neurodegenerative diseases

21 January 2018

1 reference

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

21 January 2018

1 reference

The role of iron imaging in Huntington's disease

21 January 2018

1 reference

Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases.

21 January 2018

1 reference

Serum ferritin deficiency in Huntington's disease patients

21 January 2018

1 reference

Molecular pathways to neurodegeneration

21 January 2018

1 reference

Bioenergetic and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

Nitric oxide signaling in the nervous system

21 January 2018

1 reference

Replicating Huntington's disease phenotype in experimental animals

21 January 2018

1 reference

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

21 January 2018

1 reference

Metal complexing agents as therapies for Alzheimer's disease

21 January 2018

1 reference

Nitric oxide in cell survival: a janus molecule

21 January 2018

1 reference

Polyglutamine domain flexibility mediates the proximity between flanking sequences in huntingtin

21 January 2018

1 reference

The corticostriatal pathway in Huntington's disease

21 January 2018

1 reference

NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1.

21 January 2018

1 reference

Abcb10 physically interacts with mitoferrin-1 (Slc25a37) to enhance its stability and function in the erythroid mitochondria

21 January 2018

1 reference

Iron accumulates in Huntington's disease neurons: protection by deferoxamine

21 January 2018

1 reference

Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity

21 January 2018

1 reference

Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI.

21 January 2018

1 reference

Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation

21 January 2018

1 reference

PKA modulates iron trafficking in the striatum via small GTPase, Rhes

21 January 2018

1 reference

Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release

21 January 2018

1 reference

An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity

21 January 2018

1 reference

Relationship of iron to oligodendrocytes and myelination

21 January 2018

1 reference

Genes and the environment in neurodegeneration

21 January 2018

1 reference

Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity

21 January 2018

1 reference

Intramuscular desferrioxamine in patients with Alzheimer's disease

21 January 2018

1 reference

A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin

21 January 2018

1 reference

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

21 January 2018

1 reference

Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.

21 January 2018

1 reference

Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice

21 January 2018

1 reference

Somatic expansion of the (CAG)n repeat in Huntington disease brains

21 January 2018

1 reference

Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study

21 January 2018

1 reference

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

21 January 2018

1 reference

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

21 January 2018

1 reference

Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons

21 January 2018

1 reference

In vivo evidence for the selective subcortical degeneration in Huntington's disease.

21 January 2018

1 reference

Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice

21 January 2018

1 reference

Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?

21 January 2018

1 reference

Elevated brain iron is independent from atrophy in Huntington's Disease

21 January 2018

1 reference

Trinucleotide repeat length instability and age of onset in Huntington's disease

21 January 2018

1 reference

Inactivation of the mouse Huntington's disease gene homolog Hdh

21 January 2018

1 reference

Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models

21 January 2018

1 reference

Mouse models of Huntington disease: variations on a theme.

21 January 2018

1 reference

Preclinical Huntington's disease: compensatory brain responses during learning

21 January 2018

1 reference

Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization

21 January 2018

1 reference

Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.

21 January 2018

1 reference

Huntingtin inclusion bodies are iron-dependent centers of oxidative events.

21 January 2018

1 reference

Mechanisms of copper ion mediated Huntington's disease progression

21 January 2018

1 reference

Ferritin as an important player in neurodegeneration

21 January 2018

1 reference

Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus

21 January 2018

1 reference

Hepcidin and disorders of iron metabolism

21 January 2018

1 reference

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules

21 January 2018

1 reference

MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content

21 January 2018

1 reference

Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease

21 January 2018

1 reference

Connecting the dots in Huntington's disease with protein interaction networks

21 January 2018

1 reference

Regulation of iron transport and the role of transferrin

21 January 2018

1 reference

A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease

21 January 2018

1 reference

DNA instability in postmitotic neurons

21 January 2018

1 reference

Iron porphyrinate Fe(TPPS) reduces brain cell damage in rats intrastriatally lesioned by quinolinate

21 January 2018

1 reference

Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice

21 January 2018

1 reference

Genetics of neurodegeneration with brain iron accumulation

21 January 2018

1 reference

Signal intensity on MRI of basal ganglia in multiple sclerosis

21 January 2018

1 reference

Mitochondrial defect in Huntington's disease caudate nucleus

21 January 2018

1 reference

In silico analysis indicates a similar gene expression pattern between human brain and testis

21 January 2018

1 reference

Huntington's disease: the case for genetic modifiers

21 January 2018

1 reference

The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration

21 January 2018

1 reference

Reactive oxygen species and the central nervous system

21 January 2018

1 reference

In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production

21 January 2018

1 reference

A delicate balance: Iron metabolism and diseases of the brain.

21 January 2018

1 reference

The hunt for huntingtin function: interaction partners tell many different stories

21 January 2018

1 reference

Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

The ferritins: molecular properties, iron storage function and cellular regulation

21 January 2018

1 reference

Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum

21 January 2018

1 reference

Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome.

21 January 2018

1 reference

Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease

21 January 2018

1 reference

Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease

21 January 2018

1 reference

Paradoxical effects of copper and manganese on brain mitochondrial function

21 January 2018

1 reference

DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task.

21 January 2018

1 reference

Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles

21 January 2018

1 reference

Neuronal and behavioural abnormalities in striatal function in DARPP-32-mutant mice

21 January 2018

1 reference

Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease

21 January 2018

1 reference

New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN.

21 January 2018

1 reference

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

21 January 2018

1 reference

The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease

21 January 2018

1 reference

Magnetic field correlation imaging.

21 January 2018

1 reference

Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system

21 January 2018

1 reference

Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease

21 January 2018

1 reference

MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease

21 January 2018

1 reference

Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme

21 January 2018

1 reference

Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis.

21 January 2018

1 reference

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

21 January 2018

1 reference

Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.

21 January 2018

1 reference

Secondary Structure of Huntingtin Amino-Terminal Region

21 January 2018

1 reference

21 January 2018

1 reference

The history of iron in the brain

21 January 2018

1 reference

LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity

21 January 2018

1 reference

Neuroimaging features of neurodegeneration with brain iron accumulation.

21 January 2018

1 reference

Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.

21 January 2018

1 reference

Identification of a Steap3 endosomal targeting motif essential for normal iron metabolism

21 January 2018

1 reference

Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo

21 January 2018

1 reference

Wild-type huntingtin protects neurons from excitotoxicity

21 January 2018

1 reference

Expression of multiple glutamate transporter splice variants in the rodent testis

21 January 2018

1 reference

Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export.

21 January 2018

1 reference

A human mitochondrial ferritin encoded by an intronless gene

21 January 2018

1 reference

Proteasomal dysfunction in aging and Huntington disease

21 January 2018

1 reference

Huntington's disease: a synaptopathy?

21 January 2018

1 reference

Huntingtin-deficient zebrafish exhibit defects in iron utilization and development.

21 January 2018

1 reference

Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions

21 January 2018

1 reference

Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity

21 January 2018

1 reference

Huntington's disease: translating a CAG repeat into a pathogenic mechanism

21 January 2018

1 reference

Huntington's disease. Pathogenesis and management

21 January 2018

1 reference

Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease

21 January 2018

1 reference

Iron alters glutamate secretion by regulating cytosolic aconitase activity

21 January 2018

1 reference

Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease

21 January 2018

1 reference

Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy

21 January 2018

1 reference

Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease

21 January 2018

1 reference

Life without huntingtin: normal differentiation into functional neurons

21 January 2018

1 reference

Huntingtin is required for normal hematopoiesis

21 January 2018

1 reference

HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2

21 January 2018

1 reference

NMDA receptor function and NMDA receptor-dependent phosphorylation of huntingtin is altered by the endocytic protein HIP1

21 January 2018

1 reference

Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts.

21 January 2018

1 reference

Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease

21 January 2018

1 reference

Use of desferrioxamine in the treatment of aceruloplasminemia

21 January 2018

1 reference

Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease

21 January 2018

1 reference

Serum iron, total iron binding capacity and ferritin in early Huntington disease patients

21 January 2018

1 reference

Multiple Aspects of Gene Dysregulation in Huntington's Disease

21 January 2018

1 reference

Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus

21 January 2018

1 reference

Autophagosome-like vacuole formation in Huntington's disease lymphoblasts

21 January 2018

1 reference

Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes

21 January 2018

1 reference

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

21 January 2018

1 reference

Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model

21 January 2018

1 reference

Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment

21 January 2018

1 reference

21 January 2018

Huntington's disease.

1 reference

Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin

21 January 2018

1 reference

Deferiprone for the treatment of Friedreich's ataxia.

21 January 2018

1 reference

Iron metabolism and the IRE/IRP regulatory system: an update

21 January 2018

1 reference

Mechanisms of mammalian iron homeostasis

21 January 2018

1 reference

Hepcidin, a urinary antimicrobial peptide synthesized in the liver

21 January 2018

1 reference

Striatal and white matter predictors of estimated diagnosis for Huntington disease

21 January 2018

1 reference

Microglial activation correlates with severity in Huntington disease: a clinical and PET study.

21 January 2018

1 reference

Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).

21 January 2018

1 reference

Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease

21 January 2018

1 reference

MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods.

21 January 2018

1 reference

Coming into view: eukaryotic iron chaperones and intracellular iron delivery

21 January 2018

1 reference

Biological significance of iron-related magnetic resonance imaging changes in the brain

21 January 2018

1 reference

NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration

21 January 2018

1 reference

The Ras homolog Rhes affects dopamine D1 and D2 receptor-mediated behavior in mice

21 January 2018

1 reference

The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin.

21 January 2018

1 reference

Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease

21 January 2018

1 reference

Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-α and TGF-β1.

21 January 2018

1 reference

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease

21 January 2018

1 reference

Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease

21 January 2018

1 reference

Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol

21 January 2018

1 reference

Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing

21 January 2018

1 reference

Striatal volume loss in HD as measured by MRI and the influence of CAG repeat

21 January 2018

1 reference

Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis

21 January 2018

1 reference

Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.

21 January 2018

1 reference

Alterations in brain transition metals in Huntington disease: an evolving and intricate story

21 January 2018

1 reference

Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT.

21 January 2018

1 reference

Systemic iron metabolism: a review and implications for brain iron metabolism

21 January 2018

1 reference

Iron metabolism in the CNS: implications for neurodegenerative diseases

21 January 2018

1 reference

Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments

21 January 2018

1 reference

Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number

21 January 2018

1 reference

Hereditary haemochromatosis is unlikely to cause movement disorders--a critical review

21 January 2018

1 reference

Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging.

21 January 2018

1 reference

Mitochondrial ferritin expression in adult mouse tissues

21 January 2018

1 reference

Huntington's disease: the current state of research with peripheral tissues.

21 January 2018

1 reference

Golgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease

21 January 2018

1 reference

Magnetic resonance imaging of brain iron

21 January 2018

1 reference

Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicity

21 January 2018

1 reference

The effect of formalin fixation on the levels of brain transition metals in archived samples

21 January 2018

1 reference

Iron efflux from oligodendrocytes is differentially regulated in gray and white matter.

21 January 2018

1 reference

Loss of striatal serotonin synaptic receptor binding induced by kainic acid lesions: correlations with Huntington's Disease1

21 January 2018

1 reference

CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease

21 January 2018

1 reference

Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation

21 January 2018

1 reference

Cu2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo

21 January 2018

1 reference

A cytosolic iron chaperone that delivers iron to ferritin.

21 January 2018

1 reference

Huntingtin regulates RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) nuclear trafficking indirectly through a complex with REST/NRSF-interacting LIM domain protein (RILP) and dynactin p150 Glued

21 January 2018

1 reference

Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease

21 January 2018

1 reference

Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles

21 January 2018

1 reference

Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-D-aspartate receptors

21 January 2018

1 reference

Proteomic and oxidative stress analysis in human brain samples of Huntington disease.

21 January 2018

1 reference

Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism

21 January 2018

1 reference

Protein oxidation in Huntington disease.

21 January 2018

1 reference

Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro

21 January 2018

1 reference

Iron in chronic brain disorders: imaging and neurotherapeutic implications

21 January 2018

1 reference

SUMO modification of Huntingtin and Huntington's disease pathology

21 January 2018

1 reference

Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity

21 January 2018

1 reference

Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95.

21 January 2018

1 reference

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data

21 January 2018

1 reference

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis

21 January 2018

1 reference

Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1

21 January 2018

1 reference

Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease.

21 January 2018

1 reference

Phylogenetic comparison of huntingtin homologues reveals the appearance of a primitive polyQ in sea urchin

21 January 2018

1 reference

IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome.

21 January 2018

1 reference

Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease

21 January 2018

1 reference

Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells

21 January 2018

1 reference

Important role of oxidative stress biomarkers in Huntington's disease.

21 January 2018

1 reference

Reliability of two techniques for assessing cerebral iron deposits with structural magnetic resonance imaging.

21 January 2018

1 reference

Misfolded CuZnSOD and amyotrophic lateral sclerosis

21 January 2018

1 reference

Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease

21 January 2018

1 reference

Body weight is modulated by levels of full-length huntingtin

21 January 2018

1 reference

Testicular degeneration in Huntington disease.

21 January 2018

1 reference

The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors

21 January 2018

1 reference

Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways

21 January 2018

1 reference

MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters.

21 January 2018

1 reference

Does hereditary hemochromatosis influence the age of onset of Huntington's disease?

21 January 2018

1 reference

Regulation of cellular iron metabolism

21 January 2018

1 reference

Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo

21 January 2018

1 reference

Iron metabolism in the anemia of chronic disease.

21 January 2018

1 reference

Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration

21 January 2018

1 reference

Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system.

21 January 2018

1 reference

Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure

21 January 2018

1 reference

Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin

21 January 2018

1 reference

Huntingtin contains a highly conserved nuclear export signal

21 January 2018

1 reference

Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function

21 January 2018

1 reference

The possible role of iron in the etiopathology of Parkinson's disease

21 January 2018

1 reference

Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

21 January 2018

1 reference

Vesicular glycolysis provides on-board energy for fast axonal transport

21 January 2018

1 reference

Iron, brain ageing and neurodegenerative disorders

21 January 2018

1 reference

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease

21 January 2018

1 reference

Depletion of wild-type huntingtin in mouse models of neurologic diseases

21 January 2018

1 reference

Huntingtin inhibits caspase-3 activation

21 January 2018

1 reference

Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice.

21 January 2018

1 reference

Role of brain-derived neurotrophic factor in Huntington's disease

21 January 2018

1 reference

Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease

21 January 2018

1 reference

Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene

21 January 2018

1 reference

Quantitative MR imaging of brain iron: a postmortem validation study

21 January 2018

1 reference

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

21 January 2018

1 reference

Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity

21 January 2018

1 reference

Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy

21 January 2018

1 reference

7 January 2021

The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration

1 reference

7 January 2021

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1 reference

7 January 2021

Human ferritin H-chains can be obtained in non-assembled stable forms which have ferroxidase activity

1 reference

7 January 2021

Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease

1 reference

7 January 2021

Iron(II) and hydrogen peroxide detoxification by human H-chain ferritin. An EPR spin-trapping study

1 reference

7 January 2021

MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation

1 reference

7 January 2021

Neuropathological classification of Huntington's disease

1 reference

7 January 2021

Lactotransferrin binding to its platelet receptor inhibits platelet aggregation

1 reference

7 January 2021

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

7 January 2021

Oxidative stress in Huntington's disease

1 reference

7 January 2021

Hepcidin regulation by innate immune and infectious stimuli

1 reference

7 January 2021

Chronic quinolinic acid lesions in rats closely resemble Huntington's disease

1 reference

7 January 2021

Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons

1 reference

7 January 2021

Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum.

1 reference

7 January 2021

Wild-type huntingtin protects from apoptosis upstream of caspase-3.

1 reference

7 January 2021

Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area.

1 reference

7 January 2021

Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.

1 reference

7 January 2021

1 reference

7 January 2021

release_4dsuyyfefnfcxhtuaidre5f4xu

Identifiers

DOI

10.1111/JNC.12739

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4dsuyyfefnfcxhtuaidre5f4xu

24 November 2022

mapped directly with Wikidata item

PubMed publication ID

24717009

1 reference